Clinical Trials Directory

Trials / Terminated

TerminatedNCT00244894

Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer

Acupuncture for Hot Flashes in Prostate Cancer Patients

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
OHSU Knight Cancer Institute · Academic / Other
Sex
Male
Age
18 Years – 120 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Acupuncture may help relieve hot flashes in patients with prostate cancer. PURPOSE: This clinical trial is studying how well acupuncture works in treating hot flashes in patients with prostate cancer who are undergoing androgen deprivation.

Detailed description

OBJECTIVES: * Determine the impact of acupuncture therapy on the frequency and intensity of hot flashes and the quality of life of patients with prostate cancer undergoing androgen deprivation. * Determine if blood serotonin and urinary 5-HIAA are increased in patients treated with acupuncture. * Determine if plasma calcitonin gene-related peptide and MHPG are reduced in patients with hot flashes due to androgen deprivation treated with acupuncture. * Determine the ability of tongue diagnosis, a traditional Chinese clinical assessment method, to predict clinical and biological changes in these patients. * Determine the effect of acupuncture on insomnia and loss of vitality caused by hot flashes in these patients. OUTLINE: Patients undergo acupuncture for 30 minutes twice weekly for 4 weeks and then once weekly for an additional 6 weeks. Quality of life is assessed at baseline, at weeks 2, 4, 6, and 10, and then at 6 weeks after completion of study treatment. After completion of study treatment, patients are followed at 6 weeks. PROJECTED ACCRUAL: A total of 25 patients will be accrued for this study.

Conditions

Interventions

TypeNameDescription
PROCEDUREacupuncture therapyAcupuncture treatments will be administered by a qualified practitioner twice a week for the first four weeks and once per week for an additional 6 weeks. Sterile, disposable Seirin needles will be placed bilaterally at the point Gallbladder 34, and along the spine at Bladder 15, Bladder 23, and Bladder 32. Low intensity electrostimulation at 2 Hz will be used for both Bladder 23 and Bladder 32. Points will also be placed unilaterally at Governing vessel 20, Heart 7, Pericardium 6, Liver 2, and Spleen 6
PROCEDUREfatigue assessment and managementPatients will utilize the Pittsburgh Sleep Quality Index (PSQI) to assess if the patient is an overall good sleeper or a poor sleeper.
PROCEDUREhot flashes attenuationPatients will be asked to report hot flash frequency and severity daily using the hot flash diary (HFD) and hot flash severity guidelines (HFSG) throughout the treatment period.
PROCEDUREmanagement of therapy complicationsShort Form Health Survey (SF-36) will be used to assess the patient's overall vitality.
PROCEDUREquality-of-life assessmentHot Flash Related Daily Interference Scale (HFRDIS)will be used to self-report hot flash related quality of life.

Timeline

Start date
2002-09-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2005-10-27
Last updated
2017-04-28

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00244894. Inclusion in this directory is not an endorsement.